ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

Major League Baseball Begins Struggle to Eject Ever-Present Smokeless Tobacco Forom The Sport

April 12, 1991

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

CPRIT Executive Director Bill Gimson Is Out As Scandal Grows, Investigations Begin

December 14, 2012

Wyden Asks Healy To Clarify CRADA Pricing Clause

January 3, 1992

Obama Picks Hamburg for FDA Commissioner

March 20, 2009

Professional Societies: AACR Awards Honor 8 Scientists, Clinicians

April 2, 1999